Despite the government’s calls for more appropriate, evidence-based antimicrobial prescribing, the expansion of new pathways in community pharmacy outside Medicare and PBS is forcing “gaps in implementation and policy coherence”, the AMA says.

In its latest report on antimicrobial resistance (AMR) in Australia, released today, the AMA noted that under state-based frameworks, some pharmacists can still prescribe trimethoprim for uncomplicated cystitis without a GP prescription.

But its concern went beyond state and federal tensions. The Women’s Health Trial widened access to uncomplicated UTI treatment to all women in October, with the trial set to commence in February 2027, outside the mechanisms used to monitor and support appropriate use, the AMA said.

In previous trials, most women received antibiotics, despite the possibility of other infections or non-bacterial causes of dysuria and urinary frequency, AMA president Dr Michael Bonning told The Medical Republic .